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Abstract
Lipopolysaccharide (LPS)-binding protein (LBP) as an acute-phase protein plays a crucial role
in innate host response to bacterial challenge. Our previous study shows that LBP expression
in human gingiva is associated with periodontal status. Porphyromonas gingivalis is a keystone
periodontopathogen, and its LPS with lipid A structural heterogeneity critically accounts for
periodontal pathogenesis. This study investigated the effects of LBP and its interactions with
two featured isoforms of P. gingivalis LPS (tetra-acylated LPS1435/1449 and penta-acylated
LPS1690) on the expression of pro-inflammatory cytokines in human oral keratinocytes (HOKs),
and the involvement of Toll-like receptor (TLR) signaling. HOKs were pre-incubated with
recombinant human LBP (rhLBP) at 10ng/ml, 100ng/ml and 1μg/ml for 1 h, followed by the
treatment of P. gingivalis LPS1690 or LPS1435/1449 for 3h or 24h respectively. The expression
of IL-6 and IL-8, and involvements of TLR2 and TLR4 were analyzed. The genes associated
with TLR signaling were assessed by PCR array. Interestingly, rhLBP per se significantly up-
regulated the expression of IL-6 and IL-8 in HOKs (p<0.05), which was blocked by TLR2 anti-
body (p<0.001). LPS1435/1449 down-regulated more significantly rhLBP-induced IL-6 and IL-8
mRNAs with reference to P. gingivalis LPS1690 (approximately 80% vs. 40%, p<0.05; and 90%
vs. 36%, p<0.001, respectively). Moreover, rhLBP markedly down-regulated the gene expres-
sion of TLRs and their adaptors such as CD180 (-2.44 folds) and MD-1 (-9.62 folds), while the
interaction of P. gingivalis LPS1435/1449 with rhLBP greatly up-regulated both transcripts (7.11
and 4.05 folds, respectively). Notably, P. gingivalis LPS1690-rhLBP interaction dramatically up-
regulated CD180 transcript (20.86 folds) and significantly down-regulated MD-1 transcript
(-6.93 folds). This pioneering study shows that rhLBP enables to enhance the expression of
pro-inflammatory cytokines in HOKs through TLR2 signaling pathway. P. gingivalis LPS with
different lipid A structures down-regulates to different extents rhLBP-induced cytokine expres-
sion, possibly through fine-tuning of the CD180-MD1 complex and relevant TLRs.
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Introduction
Lipopolysaccharide (LPS)-binding protein (LBP) as an acute-phase protein is primarily pro-
duced by hepatocytes [1]. It regulates the property of LPS and modulates innate host responses
to bacterial challenge [2]. LBP has a classical dual role, namely enhancing LPS-induced cellular
activation at a low concentration and neutralizing the effects of bacterial endotoxins at a high
concentration [3,4]. Additionally, it could interact with bacteria and other bacterial compo-
nents [5–7]. In addition to hepatocytes, LBP could be synthesized by intestinal epithelial cells
[8] and respiratory type II epithelial cells [9]. It is worthy to note that our early study shows
that human gingival epithelia can produce LBP with a well-lined expression at the dentogingi-
val niche, and its expression level in periodontally healthy subjects is significantly higher than
that in chronic periodontitis patients. These findings suggest that LBP may be significantly
involved in innate response to bacterial LPS, and critically contribute to periodontal pathogen-
esis [10]. Further investigation confirms that a strong interplay of LBP and cytokines is closely
associated with periodontal conditions [11,12]. Taken together, these studies indicate that LBP
expression in gingiva instantly acts on bacterial challenge and greatly accounts for periodontal
homeostasis.
Porphyromonas gingivalis as a keystone periodontal pathogen may cause the shift of probi-
otic biofilms to pathogenic ones, and thereby result in the initiation and development of peri-
odontal disease [13]. P. gingivalis LPS is one of the key virulence factors that is significantly
involved in periodontal pathogenesis [14]. Interestingly, P. gingivalis could express two featured
isoforms of LPS (penta-acylated LPS1690 and tetra-acylated LPS1435/1449) through alteration of
lipid A structures under different micro-environmental conditions such as hemin levels and
culture temperatures [15,16]. It has been shown that P. gingivalis LPS1690 and LPS1435/1449 differ-
entially modulate innate host response, e.g. the expression of human β-defensin-2, pro-inflam-
matory cytokines and E-selectin [17–19]. Our recent studies further indicate that P. gingivalis
LPS1690 could stimulate LBP expression in human oral keratinocytes (HOKs) through NF-κB
and p38 MAPK signaling pathways, while P. gingivalis LPS1435/1449 is unable to do so [20, 21].
These findings collectively show that the shift of P. gingivalis LPS isoforms could crucially
account for periodontal pathogenesis through disrupting the activities of innate defense mole-
cules like LBP [22], but the underlying mechanisms need further investigation.
LBP is one of the important sensing apparatuses for Gram-negative bacterial LPS [4,22].
After binding to LBP in serum, LPS is transported to the TLR4/MD-2 signaling complex via sol-
uble or membrane-anchored cluster of differentiation 14 (CD14), thereby triggering a cascade
of pro- and anti-inflammatory responses [22]. LBP could sensitize or neutralize host cells to
LPS stimulation at different concentrations [3]. While it remains unknown whether LBP could
differentially interact with LPS lipid A structure and modulate host response. In the present
study, we investigated the effects of LBP and its interactions with P. gingivalis LPS1690 and
LPS1435/1449 on the expression of pro-inflammatory cytokines in HOKs, as well as the involve-
ment of TLR signaling pathways. Interestingly, we found that LBP per se enabled to markedly
up-regulate the expression of IL-6 and IL-8, and different isoforms of P. gingivalis LPS could
interact differently with LBP and down-regulate to a great extent LBP-induced cytokine expres-
sion, likely through fine-tuning of the activities of CD180–MD1 complex and relevant TLRs.
Materials and methods
Cell culture
The primary HOKs were obtained from ScienCell Research Laboratories (Carlsbad, USA),
and they were used in our recent study [20,21]. Cells were incubated in a serum-free oral
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keratinocyte medium (OKM) containing basal medium, 1% of growth factor supplement to
HOKs and 1% of streptomycin and penicillin solution at 37˚C with 5% CO2. The OKM was
replaced every other day until the cells reached around 50% confluent, and it was then replaced
daily. Cells at 3rd or 4th passages were subsequently employed in the experiments.
Preparation of P. gingivalis LPS and LBP, and their interactions with
HOKs
P. gingivalis (ATCC 33277) LPS was prepared by a well-established protocol via digesting cell
extracts with proteinase K, and successive solubilization and precipitation [20,23,24]. The LPS
was then purified by removal of endotoxin protein. The fraction of fatty acids was assessed by
gas chromatography-mass spectroscopy, and tetra- (LPS1435/1449) and penta-acylated (LPS1690)
lipid A structures were analyzed by the matrix-assisted laser desorption ionization time-of-
flight mass spectrometry [20]. According to our previous studies [20,21], P. gingivalis LPS1690
(100ng/ml) and LPS1435/1449 (100ng/ml) were selected for the subsequent experiments. Recom-
binant human LBP (rhLBP) was obtained from the R & D Systems, Inc. (Minneapolis, MN,
USA), and it was tested to have a purity over 97% by SDS-PAGE with the endotoxin level less
than 0.10 EU per 1 μg of the protein by the limulus amebocyte lysate assay. Cells were pre-
incubated with rhLBP at 10ng/ml, 100ng/ml and 1μg/ml for 1 h, prior to incubation with
100ng/ml of P. gingivalis LPS1690 or LPS1435/1449 for assessing the expression of mRNAs at 3 h
and proteins at 24 h, respectively. Cells incubated with culture medium alone served as the
negative controls.
Reverse transcription and real-time PCR
Total cellular RNA was extracted from HOKs by RNeasy Mini Kit (Qiagen, Hilden, Germany),
and 1 mg of RNA from each sample was reverse transcribed into cDNA in a final volume of
20μl with the QuantiTect1 Reverse Transcription kit (Qiagen). RT-PCR was undertaken with
the StepOne RT-PCR System (Applied Biosystems, Foster City, CA, USA), and β-actin served
as the internal control. The primer sequences were as follows: IL-6 (NM_000600.3), for-
ward: 5’-AATCATCACTGGTCTTTTGGAG-3’;reverse:5’-GCATTTGTGGTTGGGT
CA-3’;IL-8 (NM_000584.3),forward:5’-GACATACTCCAAACCTTTCCACC-3’;
reverse:5’-AACTTCTCCACAACCCTCTGC-3’, and β-Actin(NM_001101.3),
forward:5’-TTGGCA ATG AGC GGT T-3’; reverse:5’- AGT TGA AGG TAG TTT
CGT GGA T-3’. The reaction conditions were set at 95˚C for 20s, followed by 40 cycles at
95˚C for 3s and 60˚C for 30s. The data were analyzed by the comparative cycle threshold (Ct)
method [25].
Enzyme-linked immunosorbent assay (ELISA)
The levels of IL-6 and IL-8 in culture media were analyzed by ELISA (R & D Systems). The
absorbance values were measured by a microplate reader (Victor, Vienna, VA, USA) at an
optical absorbance of 450nm. The final concentrations were calculated with reference to the
standard curves for IL-6 and IL-8, respectively.
Blocking assay
The efficiency and specificity of anti-human TLR2 and TLR4 monoclonal antibodies (mAbs)
(eBioscienceInc., San Diego, CA, USA) were tested as reported in our recent study [20].
Pam3Cys as a synthetic lipopeptide and TLR2 agonist was used to determine the blocking effi-
ciency of anti-TLR2 mAb. Meanwhile, E. coli LPS as a representative TLR4 agonist was
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employed as the positive controls for the efficiency of anti-TLR4 mAb. HOKs were pre-incu-
bated for 1 h with anti-TLR2 or anti-TLR4 mAbs at 10μg/ml, prior to incubation with 100ng/ml
of Pam3Cys and E. coli LPS for 4 h (mRNAs) and 25 h (protein), respectively. IL-6 as a marker
involved in TLR signaling pathways served as the outcome measure. Both anti-TLR2 and anti-
TLR4 mAbs at 10μg/ml significantly blocked Pam3Cys- and E. coli LPS-induced IL-6 expres-
sion, respectively. The transcript and protein levels of IL-6 and IL-8 were detected by RT-PCR
and ELISA, respectively. The cells incubated with OKM alone was used as the negative control,
and those incubated with rhLBP and IgG served as the positive controls.
Assay of human TLR signaling pathway
Total cellular RNA was reverse transcribed to cDNA by the RT2 First Strand Kit (SABios-
ciences, Frederick, MD, USA). RT-PCR and data analysis were performed with the standard
protocol of RT2 ProfilerTM PCR Array System Human Toll-Like Receptor Signaling Pathway
(SABiosciences). Briefly, cDNA templates were mixed with the RT2 qPCR master mix and
H2O to form a 25μl cocktail. The cocktails were then aliquoted into each well coated with 96
different primers. The RT-PCR reaction conditions were set at 95˚C for 10 min, followed by
40 cycles at 95˚C for 15 s and 60˚C for 1 min. Data analysis was performed using the SABios-
ciences web-based software for PCR array.
Statistical analysis
Each experiment was performed in three replicates for each of three independent assays, and
the data were presented as mean±SD. When both the normality test and test of homogeneity
of variances were justified, the significant difference was analyzed by one-way ANOVA (Dun-
nett or Bonferroni or LSD test), otherwise by non-parametric methods. A p-value less than
0.05 was determined to be statistically significant. The datasets were analyzed by the IBM SPSS
Statistic 19 (SPSS Inc, IBM Corp., Armonk, NY, USA).
Results
rhLBP and its interactions with P. gingivalis LPS modulated IL-6 and IL-8
expression
It was worthy to note that rhLBP per se at 100ng/ml markedly up-regulated the transcript
expression of IL-6 and IL-8 in HOKs at 3 h (Figs 1A and 2A) (p<0.05), as well as their protein
expression at 24 h (Figs 1B and 2B) (p<0.001), respectively. Overall, the interaction of rhLBP
with P. gingivalis LPS1690 or LPS1435/1449 down-regulated to different extents IL-6 and IL-8
expression, with reference to the controls. Notably, P. gingivalis LPS1435/1449 down-regulated
rhLBP (100ng/ml)-induced IL-6 and IL-8 mRNAs more significantly than LPS1690 did (around
80% vs. 40%, p<0.05; and 90% vs. 36%, p<0.001, respectively) (Figs 1A and 2A). Moreover,
LPS1435/1449 greatly down-regulated rhLBP-induced expression of IL-6 and IL-8 proteins, with
reference to the controls (p<0.05) (Figs 1B and 2B).
TLR2 antibody neutralized rhLBP up-regulated expression of IL-6 and
IL-8
Next, to clarify whether TLR2 or TLR4 was involved in rhLBP-induced IL-6 and IL-8 expres-
sion in HOKs, blocking assays were undertaken. Pre-incubation with TLR2 mAb markedly
blocked rhLBP-induced expression of IL-6 mRNA at 4 h (Fig 3A) as well as IL-6 (Fig 3B) and
IL-8 proteins (Fig 4B) at 25 h (p<0.001). However, both IL-6 and IL-8 expression could not be
significantly blocked by TLR4 mAb (Figs 3 and 4).
LPS-binding protein modulation of pro-inflammatory response
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rhLBP and its interactions with P. gingivalis LPS modulated the
expression of genes associated with TLR signaling
A cluster of 89 genes involved in TLR signal transduction was analyzed simultaneously. HOKs
were pretreated with rhLBP at 100ng/ml for 1 h, prior to incubation with 100ng/ml of P. gingi-
valis LPS1690 or LPS1435/1449 for 3h. As shown in Table 1, the downstream pathways of NF-KB,
JNK/p38 and IRF were greatly involved in rhLBP-induced cytokine expression. Notably, the
Fig 1. rhLBP and its interactions with P. gingivalis LPS1690 and LPS1435/1449 modulated the expression of IL-6 mRNA (A) and protein (B) in HOKs. rhLBP
per se at 100ng/ml markedly up-regulated the transcript expression of IL-6 by around 5 folds at 3 h (A) (p<0.05), as well as its protein expression by around
3 folds at 24 h (B) (p<0.001). Notably, LPS1435/1449 down-regulated rhLBP (100ng/ml)-induced IL-6 more significantly than LPS1690 (around 80% vs. 40%,
p<0.05) (A). One representative experiment of three is presented. *p < 0.05, **p < 0.001.
https://doi.org/10.1371/journal.pone.0173223.g001
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key mediators of TLRs and their adaptors such as CD180 (a TLR4 antagonist) and MD-1 (a
MD-2 homolog) were significantly down-regulated by rhLBP per se. Both CD180 and MD-1
were dramatically up-regulated by P. gingivalis LPS1435/1449, whereas these two genes were
reversely modulated by P. gingivalis LPS1690 (20.86 folds and -6.93 folds, respectively).
Fig 2. rhLBP and its interactions with P. gingivalis LPS1690 and LPS1435/1449 modulated the expression of IL-8 mRNA (A) and protein (B) in HOKs. rhLBP
per se at 100ng/ml markedly up-regulated the transcript expression of IL-8 by around 11 folds at 3 h (A) (p<0.05), as well as its protein expression by around
2 folds at 24 h (B) (p<0.001). Notably, LPS1435/1449 down-regulated rhLBP (100ng/ml)-induced IL-8 mRNAs more significantly than LPS1690 (around 90%
vs. 36%, p<0.001) (A). LPS1435/1449 down-regulated rhLBP (1μg/ml)-induced IL-8 proteins more significantly than LPS1690 (B). One representative
experiment of three is presented. *p < 0.05, **p < 0.001.
https://doi.org/10.1371/journal.pone.0173223.g002
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Discussion
LBP as an acute phase protein plays an important role in modulation of immuno-inflamma-
tory response to bacterial LPS [4]. It functions as a shuttle protein to remove the monomer of
LPS molecules from LPS aggregates, transporting them to cell surfaces and then getting back
to the aggregates [2]. Moreover, LBP is not only present as a soluble form but also exists in a
membrane-bound form (mLBP) that intercalates into cell membrane. It acts as a fusion pro-
tein for LPS aggregates to lipid membranes [26–29]. However, the other functions of LBP
Fig 3. TLR2 antibody neutralized the modulatory effects of rhLBP on IL-6 expression in HOKs. Pre-
incubation with TLR2 mAb (10μg/ml) significantly blocked rhLBP-induced expression of IL-6 mRNA at 4 h (A) and
its protein at 25 h (B). However, both IL-6 mRNA and protein expression could not be significantly blocked by TLR4
mAb. One representative experiment of three is presented. *p < 0.05, **p < 0.001.
https://doi.org/10.1371/journal.pone.0173223.g003
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remain to be investigated. Classical studies have shown that the dual concentration-dependent
effects of LBP in its interaction with LPS act through different approaches, i.e. enhancement of
bacteria-induced cellular activation at a low concentration through mLBP intercalation, and
neutralization of the LPS effects at a high concentration through soluble LBP [3, 27]. Although
the active interactions of LBP with LPS or other bacterial components have been well docu-
mented, it is considered that LBP alone is unable to induce detectable expression of TNF
Fig 4. TLR2 antibody neutralized the modulatory effects of rhLBP on IL-8 expression in HOKs. IL-8 mRNA
expression was down-regulated about 3 folds after TLR2 neutralization by TLR2 mAb at 10μg/ml, although there was
no significant difference (A). Whereas, pre-incubation with TLR2 mAb (10μg/ml) significantly blocked rhLBP-induced
expression of IL-8 protein at 25 h (B). However, both IL-8 mRNA and protein expression could not be significantly
blocked by TLR4 mAb. One representative experiment of three is presented. *p < 0.05, **p < 0.001.
https://doi.org/10.1371/journal.pone.0173223.g004
LPS-binding protein modulation of pro-inflammatory response
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mRNA and protein [2]. Interestingly, our present study reveals that rhLBP per se enables to
significantly modulate the expression of pro-inflammatory cytokines and related TLR signal-
ing molecules in HOKs with reference to the negative controls. This observation could be elab-
orated from different lines. Firstly, the discovery of LBP as a transmembrane protein makes it
structurally possible to induce signaling pathway without necessary interaction with LPS [28].
The soluble rhLBP added in the culture media may intercalate directly into the cell membrane,
thereby interacting with other cytoplasmic receptors and subsequently inducing cell activation.
Secondly, LBP appears to be able to bind not only to LPS, but also to other bacterial com-
pounds including viable bacteria per se and other surface patterns such as lipoproteins, lipotei-
choic acid (LTA) and glycolipids [30]. According to the manufacturer, the rhLBP used in the
present study has been tested with its purity above 97% and endotoxin level below 0.10 EU/
1 μg of the protein. Although it is unlikely that the interaction of rhLBP with other ligands
induces notable cellular response, such a possibility could not be entirely excluded. Further-
more, alternative protein control such as heat-denatured LBP protein could have been added
for additional reference other than the negative control used. Further study is required to clar-
ify the current findings and underlying mechanisms.
TLR2 and TLR4 are strongly involved in the expression of immuno-inflammatory mole-
cules. TLR2 could dimerize with other TLRs for recognition of a diversity of structurally differ-
ent ligands from bacteria and fungi. The TLR2 ligands include triacylated lipopeptides like
Pam3CSK4 that interacts with TLR1/TLR2, and diacylated lipid/lipopeptides like LTA and
Mycoplasma fermentan interacting with TLR2/TLR6 complex [31]. TLR4 is mainly involved in
Table 1. The changes of gene expression associated with the Toll-like receptor signaling in the three test groups of HOKs with reference to the
control cells. The genes up-regulated over 2 folds are highlighted in bold, and those down-regulated over 2 folds are marked in bold italics.
Functions Gene products Fold change with reference to the control group
rhLBP rhLBP + P. gingivalis LPS1690 rhLBP + P. gingivalis LPS1435/1449
Toll-like receptors CD180 -2.44 20.86 7.11
TLR1 -1.24 -1.56 -2.07
TLR8 1.14 1.59 4.04
TLR9 -1.61 1.09 -2.18
TLR10 1.91 -1.66 -4.65
Adaptors & TLR interacting protein BTK 1.12 3.40 3.97
MD-1 -9.62 -6.93 4.05
NF-KB pathway CSF2 2.33 3.63 1.28
CSF3 1.72 2.05 1.08
INFB1 9.15 8.89 0.77
IFNG 1.14 1.59 4.05
IL2 1.14 1.59 19.15
IL-6 9 2.49 0.86
IL-8 13.19 6.00 1.13
IL10 0.98 2.59 4.39
LTA 1.21 2.09 0.69
JNK/p38 pathway FOS 2.04 1.98 1.15
NF/IL-6 pathway CLEC4E 1.14 14.07 12.36
PTGS2 2.68 2.78 0.63
IRF pathway CXCL10 2.1 2.13 1.22
IFNB1 9.15 8.89 1.14
IFNG 1.14 1.59 4.05
Regulation of adaptive immunity CD86 -1.95 -5.18 -4.57
https://doi.org/10.1371/journal.pone.0173223.t001
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LPS-induced signaling [32]. In the present study, rhLBP up-regulated the expression of IL-6
and IL8 could be greatly down-regulated by anti-TLR2 mAb but not anti-TLR4 mAb, suggest-
ing that TLR2 signaling may critically account for rhLBP-induced expression of pro-inflam-
matory cytokines.
It has recently been shown that P. gingivalis LPS may be shifted from its penta-acylated
LPS1690 isoform to the tetra-acylated LPS1435/1449 isoform in high hemin levels and increased
culture temperature [15,16]. Our previous studies have shown that the expression of pro-
inflammatory mediators and antimicrobial proteins could be significantly dysregulated by
P. gingivalis LPS1435/1449, and the innate host defense may therefore be weakened, thereby con-
tributing to periodontal pathogenesis [17,18, 20–22]. As shown in the present study, rhLBP
per se can act on host cells to promote the expression of pro-inflammatory cytokines and mod-
ulate immuno-inflammatory response. As P. gingivalis LPS1435/1449 could more significantly
down-regulate rhLBP-induced expression of IL-6 and IL-8 with reference to P. gingivalis
LPS1690, rhLBP could function as a potential innate immune enhancer and contribute to peri-
odontal homeostasis. Its possible clinical uses and relevant implications are warranted for fur-
ther investigation. In addition, currently it remains unknown how and to what extents host
cells may respond to different phenotypes of P. gingivalis cells with heterogeneous lipid A
structures of LPS under various microenvironmental conditions. Hopefully, our ongoing
study on the modulatory effects of various phenotypes of P. gingivalis cells on the expression
profiles of innate host defense molecules could shed some light on this important issue.
Our present study suggests that the downstream pathways of NF-KB, JNK/p38 and IRF may
be involved in rhLBP-enhanced cytokine expression. Notably, the key mediators of TLRs and
their adaptive proteins such as CD180 and MD-1 could be significantly down-regulated by
rhLBP. Moreover, both CD180 and MD-1 mRNAs were dramatically up-regulated by P. gingi-
valis LPS1435/1449, while these transcripts were reversely modulated by P. gingivalis LPS1690
(20.86 folds and -6.93 folds, respectively). The MD-2/TLR4-dependent host response to bacte-
rial LPS is related to the complex of MD-1 and TLR homolog radioprotective 105 (RP105, also
termed as CD180) [33]. CD180 as a type I transmembrane protein shares about 30% sequence
identity with TLR4, and MD-1 sharing around 20% similarity with MD-2 belongs to the same
family of MD-2 with a defined lipid binding function [34,35]. MD-1 has been identified as a
molecule strongly associated with CD180 [36]. Indeed, CD180/MD-1 as a cell surface molecu-
lar complex in the TLR family crucially controls LPS-induced downstream signaling [37].
Besides the common features of CD180/MD-1 and MD-2/TLR4, they are also functionally
interrelated. It has been confirmed that the LPS action can be inhibited by CD180/MD-1
through interacting with MD-2/TLR4 in HEK293 cells and immune cells such as dendritic
cells and macrophages [38]. In B-cells, the CD180/MD-1 complex could impair the production
of TLR-dependent antibody against LPS or lipoproteins [33,39].
Based on the above findings, the underlying mechanism by which the two isoforms of P.
gingivalis LPS exert different effects on rhLBP-induced expression of pro-inflammatory cyto-
kines may be postulated. Herein, rhLBP could interact with the HOKs through various possi-
ble pathways. Firstly, as concerned above it may directly interact with other cytoplasmic
receptors and activate cells. Secondly, it could bind to the penta-acylated isoform for inducing
the TLRs signaling pathway, and/or to the tetra-acylated isoform for partially blocking the sig-
naling concerned. Moreover, the penta-acylated lipid A structures are TLR4 agonists, and the
tetra-acylated ones are antagonists to TLR4 [19, 24, 40]. Our study further shows that CD180
and MD-1, the key mediators of TLRs and their adaptors, can be significantly down-regulated
by rhLBP; while they could be greatly up-regulated by P. gingivalis LPS1435/1449. Thus, these
observations collectively suggest that rhLBP may possibly modulate to different extents the
expression of IL-6 and IL-8 induced by the different isoforms of P. gingivalis LPS, through
LPS-binding protein modulation of pro-inflammatory response
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regulation of the activity of CD180-MD1 complex that acts as an antagonist of TLR4-MD-2
complex. Further study is required to clarify the mechanisms underlying LBP modulation of
cytokine expression in HOKs.
The present study shows that rhLBP per se enables to significantly up-regulate the expres-
sion of pro-inflammatory cytokines in HOKs through TLR2 signaling pathway. P. gingivalis
LPS with different lipid A structures down-regulates to different extents rhLBP-induced cyto-
kine expression, possibly through fine-tuning of the CD180-MD1 complex and relevant TLRs.
The current findings may enhance our understanding of the innate defense mechanisms in
periodontal homeostasis. This study could contribute to the development of novel immuno-
modulators for prevention and control of common inflammatory diseases like periodontitis.
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